ESTRO 36 Programme book and exhibition guide

SYMPOSIUMWITH PROFFERED PAPERS Selection of patients and radiotherapy technique for APBI in the light of

TUESDAY 9 MAY 2017

new phase III trial data 09:15 - 10:30 | SCHUBERT Chair: J. Guinot (Spain) Co-chair: A. Resch (Austria)

09:15 > Target coverage and dose to organs at risk using different techniques of APBI (EBI, IORT, BT) L. Marrazzo (Italy) 09:33 > External beam partial breast irradiation: changing patient selection based on current evidence I. Meattini (Italy) 09:51 > Partial breast irradiation with brachytherapy: changing patient selection based on current evidence C. Polgár (Hungary) 10:09 > Accelerated PBI VS standard radiotherapy (IRMA trial): interim cosmetic and toxicity results

SP-0565

SP-0566

SP-0567

B. Meduri (Italy), A. Baldissera, M. Galeandro, E. Donini, G. Tolento, P. Giacobazzi, T. Calmieri, P. Vasilyeva, A.G. Morganti, S. Parisi, S. Kaleci, F. Lohr, R. D’amico, P.M. Poortmans, F. Bertoni, G.P. Frezza

OC-0568

10:19 > Comparison of clinical outcome of APBI by interstitial brachytherapy as per ESTRO and ASTRO guidelines T. Telkhade (India), T. Wadasadawala, R. Upereti, R. Sarin, R. Jalali, R. Badwe, V. Parmar, S. Gupta, A. Budrukkar

OC-0569

SYMPOSIUMWITH PROFFERED PAPERS Novel approaches in poor tumour control sites 09:15 - 10:30 | LEHAR 4

Despite the overall progress in cancer detection and treatment, some cancers remain difficult to detect early and poorly responsive to treatment, resulting in a dismal outcome for the patients. Speakers in this symposium will discuss novel approaches for the diagnosis and treatment of pancreatic and brain tumours, which take advantage of innovative molecularly-based techniques. Data illustrating the use of circulating tumour DNA for diagnostic and prognostic purposes will also be presented using as example HPV ctDNA detection in patients treated for anal canal squamous cell carcinoma.

Chair: S. Demaria (USA) Co-chair: C. Doeller (Austria)

SCIENTIFIC PROGRAMME | Programme and Exhibition Guide

158